Skip to main content

Viking Global Investors — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

54
Companies
$2.4B
Total invested
$51.2M
Avg. check
55
Industries
Biotechnology 14Health Care 9Therapeutics 6Health Diagnostics 4Medical 4Information Technology 4+49 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 54
Humaneva
September 2024

Humaneva is a healthacare research company that offers reliable clinical research data that empowers the medical community.

Clinical Trials · Raleigh$50.0M Private Equity
Astarte Medical
September 2021

Astarte Medical is clinical intelligence company providing digital solutions to support protocol-driven care across pediatric populations.

Analytics · Yardley$7.6M Series A
Boost Biomes
September 2021

Boost Biomes develops microbial products to sustainably improve food production and shelf-life.

Agriculture · South San FranciscoSeries A
Amylyx Pharmaceuticals
September 2025

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Biotechnology · Cambridge$175.0M Post-IPO Equity
Algen Biotechnologies
August 2021

Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.

Artificial Intelligence (AI) · San Francisco$5.4M Seed
Polaris Genomics
August 2025

Polaris Genomics identifies genomic biomarkers to support the development of psychiatric drugs and clinical tools.

Bioinformatics · Gaithersburg$250K Debt Financing
GT Medical Technologies
June 2026

GT Medical Technologies develops medical technologies to improve outcomes for patients with brain tumors.

Health Care · Tempe$100.0M Series E
Zentalis Pharmaceuticals
June 2023

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Biopharma · New York$235.5M Post-IPO Equity
NextGen Jane
May 2025

NextGen Jane is a data-driven women's health company.

Biotechnology · Oakland$2.2M Grant
Locus Biosciences
May 2022

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

Biopharma · Morrisville$35.0M Series B
Dock
May 2022

Dock is a provider of a financial technology company that integrates card issuing and core banking services.

Credit Cards · São Paulo$110.0M Private Equity
Canopy
April 2025

Canopy offers a cloud-based Practice Management solution for Accounting professionals.

Accounting · Draper$70.0M Series C
Revenova
April 2022

Revenova is a provider of CRM-powered transportation management systems (TMS) for 3PLs, Freight Brokers, Carriers and Shippers

Cloud Computing · Chicago$63.0M Venture - Series Unknown
Trace Genomics
February 2024

Trace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.

Agriculture · Burlingame$10.5M Series B
BiomEdit
July 2025

Microbiome Innovation for Animal Health

Biotechnology · Fishers$18.4M Series B
AssetWatch
April 2025

AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.

Big Data · Westerville$75.0M Series C
Ecovative Design
March 2025

Ecovative Design is a biomaterials company focused on the development of innovative materials from natural growth processes.

Advanced Materials · Albany$9.3M Venture - Series Unknown
1Health
February 2025

1Health is a health platform that connects clinicians and patients to labs.

Health Care · San Francisco$1.8M Venture - Series Unknown
MyForest Foods
February 2024

MyForest Foods grows meatless mycelium on vertical farms and supplies sustainable natural flagship products to consumers.

Alternative Protein · Albany$3.5M Venture - Series Unknown
Keboola
December 2023

Keboola is a cloud platform helping clients combine, enhance and publish crucial information for internal analytics & data products.

Analytics · London$32.0M Series A
DermBiont
October 2023

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

Biotechnology · Boston$35.2M Series B
Pragma Bio
July 2023

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Biotechnology · MillbraeSeries A
Abdera Therapeutics
April 2023

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Biotechnology · Vancouver$142.0M Series B
Mantra Bio
January 2023

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

Biotechnology · San Francisco$9.0M Series A

Where Viking Global Investors invests

Biotechnology14
Health Care9
Therapeutics6
Health Diagnostics4
Medical4
Information Technology4

About Viking Global Investors's portfolio

How many companies has Viking Global Investors invested in?

Viking Global Investors has invested in 54 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Viking Global Investors invest in?

Viking Global Investors's top investment sectors include Biotechnology, Health Care, Therapeutics, Health Diagnostics, Medical. The firm invests across 55 different industry categories.

What is Viking Global Investors's largest investment?

Among tracked funding rounds, Zentalis Pharmaceuticals received $235.5M in a Post-IPO Equity round. Viking Global Investors's total known invested capital is $2.4B.

What is the average investment size for Viking Global Investors?

Viking Global Investors's average investment size is $51.2M across its portfolio of 54 companies.

What are Viking Global Investors's most recent investments?

Recent Viking Global Investors portfolio additions include Humaneva, Astarte Medical, Boost Biomes, Amylyx Pharmaceuticals, Algen Biotechnologies. These companies were founded in 2020 or later.

Reach the founders behind these 54 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →